Tag Archives: T-cell costimulator

Oncology study: GSK starts phase I clinical trial with an investigational inducibile T-cell costimulator (ICOS) agonist antibody

GSK3359609 is the first investigational ICOS agonist antibody to enter human clinical trials LONDON, 01-Jul-2016 — /EuropaWire/ — GSK today announced the start of a phase I clinical trial with GSK3359609, an investigational inducibile T-cell costimulator (ICOS) agonist antibody. ICOS is … Read the full press release